Log In
BCIQ
Print this Print this
 

Angiotensin II type 2 (AT2) receptor (ATGR2)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Angiotensin II type 2 (AT2) receptor (ATGR2)

BCIQ
Print ChartPrint this
1 0 0 0 0 0 1 0 2 1 0 1
Phases of DevelopmentPreclinicalPhase IPhase IIMarketed
Cardiovascular

2

1

0

1

Neurology

0

0

1

0

Pulmonary

1

0

0

0




 Products Targeting Angiotensin II type 2 (AT2) receptor (ATGR2)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$22.3M

$22.3M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today